7) Donker M, van Tienhoven G, Straver ME et al : Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS) : a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol 15 : 1303-1310, 2014.
11) Jones S, Holmes FA, O'Shaughnessy J et al : Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide : 7-Year Follow-Up of US Oncology Research Trial 9735. J Clin Oncol 27 : 1177-1183, 2009.
16) Robert NJ, Dieras V, Glaspy J et al : RIBBON-1 : randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2-negative, locally recurrent or metastatic breast cancer. J Clin Oncol 29 : 1252-1260, 2011.
19) Hodi FS, O'Day SJ, McDermott DF et al : Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363 : 711-723, 2010.